Potential Market for Islet Sheet Product

The 1999 market for products to treat insulin-requiring diabetes is in the table below.

$ millions

United States


Glucose Tests






Bioartificial Pancreas






It has been estimated by the consulting firm Frost and Sullivan that the bioartificial pancreas will enter the market in 2003, and that by the year 2005 annual revenues will be $6.3 billion (thus making the bioartificial pancreas segment the largest segment of the diabetes product market). Frost and Sullivan's research identifies Islet Sheet Medical as the "Market Leader" in the Bioartificial Pancreas segment of the Artificial Organ Transplant Market.